PAVmed (PAVmed) Ending Cash Position : $25.54 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is PAVmed Ending Cash Position?

PAVmed's Ending Cash Position for the quarter that ended in Mar. 2024 was $25.54 Mil.

PAVmed's quarterly Ending Cash Position declined from Sep. 2023 ($26.41 Mil) to Dec. 2023 ($19.64 Mil) but then increased from Dec. 2023 ($19.64 Mil) to Mar. 2024 ($25.54 Mil).

PAVmed's annual Ending Cash Position declined from Dec. 2021 ($77.26 Mil) to Dec. 2022 ($39.74 Mil) and declined from Dec. 2022 ($39.74 Mil) to Dec. 2023 ($19.64 Mil).

PAVmed Ending Cash Position Historical Data

The historical data trend for PAVmed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PAVmed Ending Cash Position Chart

PAVmed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

6.22

17.26

77.26

39.74

19.64

PAVmed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															49.28	37.16	26.41	19.64	25.54

PAVmed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PAVmed's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	39.744	+	-20.105
	=	19.64

PAVmed's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	19.639	+	5.897
	=	25.54

PAVmed Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PAVmed's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PAVmed (PAVmed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PAVmed Inc (NAS:PAVMW) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PAVM:USA

Address

360 Madison Avenue, 25th Floor, New York, NY, USA, 10017

Website

http://www.pavmed.com

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard and the Veris Cancer Care Platform.